Patents by Inventor Yuanyuan Xu

Yuanyuan Xu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240131086
    Abstract: The present disclosure provides use of Clostridium ghonii combined with a tumor angiogenesis inhibitor in preparing a pharmaceutical product for treating a tumor. The present disclosure further provides a drug for treating a tumor, where the drug includes active ingredients of Clostridium ghonii and a tumor angiogenesis inhibitor.
    Type: Application
    Filed: October 9, 2022
    Publication date: April 25, 2024
    Inventors: Yong Wang, Yuanyuan Liu, Wenhua Zhang, Yanqiu Xing, Shaopeng Wang, Dan Wang, Hong Zhu, Xinglu Xu, Shengbiao Jiang, Xiaonan Li, Jiahui Zheng, Rong Zhang, Dongxia Yang, Yuxia Gao, Shili Shao, Ting Han
  • Publication number: 20240115627
    Abstract: The present disclosure relates to use of a Clostridium ghonii spore combined with pembrolizumab in cancer treatment. It is found for the first time that the Clostridium ghonii spore combined with pembrolizumab can significantly improve a curative effect of colon cancer and reduce a dose of the pembrolizumab, and thus is efficient and low-toxic. Oncolysis by Clostridium ghonii can affect immunogenicity of a tumor microenvironment (TME) by various ways, converts an immunosuppressive state of the TME into an immune-activated state, adjusts the immunosuppressive TME, and breaks an immune tolerance. An optimal combination of the Clostridium ghonii spore and the pembrolizumab thoroughly removes about 20% of mouse tumor tissues. A benefit range of patients with tumors treated by a PD-1 antibody is expanded. The combination even has an obvious curative effect on patients failed the treatment by the PD-1 antibody.
    Type: Application
    Filed: October 9, 2022
    Publication date: April 11, 2024
    Inventors: Yong Wang, Hong Zhu, Wenhua Zhang, Yanqiu Xing, Dan Wang, Yuanyuan Liu, Shaopeng Wang, Jiahui Zheng, Rong Zhang, Xiaonan Li, Xinglu Xu, Shengbiao Jiang, Lichao Xing, Yuxia Gao, Shili Shao, Ting Han
  • Patent number: 11947393
    Abstract: Disclosed are a foldable screen and a display device. The foldable screen includes: a flexible display panel and a plurality of elastic portions, wherein each of the elastic portions includes each of elastic support members and two connecting rods fixedly connected to each of the elastic support members; wherein the two connecting rods are respectively connected to two flat portions of the flexible display panel, and the elastic support members are configured to supply a support force to the foldable portion in the case that a display surface of the foldable portion of the flexible display panel is coplanar with those of the flat portions.
    Type: Grant
    Filed: March 2, 2022
    Date of Patent: April 2, 2024
    Assignees: Chengdu BOE Optoelectronics Technology Co., Ltd., BOE Technology Group Co., Ltd.
    Inventors: Renzhe Xu, Bin Zhang, Haotian Yang, Yiming Wang, Wei Gong, Jingyu Piao, Xiaodong Hao, Danyang Bi, Kang Wang, Inho Park, Xiaoliang Fu, Yuanyuan Chai, Seungyong Oh
  • Patent number: 11941854
    Abstract: Provided are a face image processing method and apparatus, an image device, and a storage medium. The face image processing method includes: acquiring first-key-point information of a first face image; performing position transformation on the first-key-point information to obtain second-key-point information conforming to a second facial geometric attribute, the second facial geometric attribute being different from a first facial geometric attribute corresponding to the first-key-point information; and performing facial texture coding processing by utilizing a neural network and the second-key-point information to obtain a second face image.
    Type: Grant
    Filed: March 16, 2021
    Date of Patent: March 26, 2024
    Assignee: Beijing SenseTime Technology Development Co., Ltd.
    Inventors: Wenyan Wu, Chen Qian, Keqiang Sun, Qianyi Wu, Yuanyuan Xu
  • Patent number: 11924513
    Abstract: Disclosed are a display apparatus and a method for displaying a user interface. In response to a preset instruction, the display apparatus acquires local images to generate a local video stream, plays a local video picture, and displays a graphic element for identifying a preset expected position in a floating layer above the local video picture. When the moving target exists in the local video picture and an offset of a target position of the moving target in the local video picture relative to the expected position is greater than a preset threshold value, a prompt control for guiding the moving target to move to the expected position is presented in the floating layer above the local video picture according to the offset of the target position relative to the expected position.
    Type: Grant
    Filed: November 18, 2021
    Date of Patent: March 5, 2024
    Assignee: JUHAOKAN TECHNOLOGY CO., LTD.
    Inventors: Guangqiang Wang, Xiaochun Xu, Zhezhe Liu, Xiangsheng Wu, Yuanyuan Li, Yinyang Chen, Yao Xie, Fanwen Zhang
  • Publication number: 20230407031
    Abstract: A foamable silicone composition, includes: (a) at least one organopolysiloxane containing at least two alkenyl groups bonded to silicon atoms per molecule, (b) at least one organopolysiloxane containing at least two hydrogen atoms bonded to silicon atoms per molecule, (c) porogenic agents generating gaseous hydrogen in the presence of component (b) comprising (c1) an organopolysiloxane containing at least one hydroxyl group bonded to silicon atom per molecule and (c2) water, and (d) hydrosilylation catalyst; with the proviso that the ratio of the number of moles of hydroxyl groups provided by component (c2) to that provided by component (c1) is within a range of from 1:5 to 20:1. The composition has a low viscosity and a relatively high pot life, and the foam cured therefrom has a low density, uniform porosity and fine cell structure.
    Type: Application
    Filed: February 3, 2021
    Publication date: December 21, 2023
    Applicant: Wacker Chemie AG
    Inventor: Yuanyuan XU
  • Patent number: 11798230
    Abstract: Embodiments of the present disclosure provide a display data processing method, device and terminal, a display method and device and a readable storage medium. The display data processing method includes: acquiring a display data saving instruction; and storing, when a display screen deforms, display data and a state parameter of display screen corresponding to the display screen to obtain a display data processing result.
    Type: Grant
    Filed: August 7, 2020
    Date of Patent: October 24, 2023
    Assignee: ZTE CORPORATION
    Inventor: Yuanyuan Xu
  • Publication number: 20230287193
    Abstract: Foamable silicone compositions, containing (A) at least one organopolysiloxane containing at least two alkenyl groups bonded to silicon per molecule, (B) at least one organopolysiloxane containing at least two hydrogen atoms bonded to silicon per molecule, (C) at least one porogenic agent generating gaseous hydrogen in the presence of component (B), and (D) at least one hydrosilylation catalyst. Foams obtained by curing such foamable silicone compositions have excellent resilience, moderate hardness, good mechanical properties, and flame retardancy, suitable for the sealing of battery pack cases.
    Type: Application
    Filed: July 2, 2020
    Publication date: September 14, 2023
    Applicant: Wacker Chemie AG
    Inventors: Yuanyuan XU, Anxiang GAO
  • Publication number: 20220254103
    Abstract: Embodiments of the present disclosure provide a display data processing method, device and terminal, a display method and device and a readable storage medium. The display data processing method includes: acquiring a display data saving instruction; and storing, when a display screen deforms, display data and a state parameter of display screen corresponding to the display screen to obtain a display data processing result.
    Type: Application
    Filed: August 7, 2020
    Publication date: August 11, 2022
    Inventor: Yuanyuan XU
  • Patent number: 11402383
    Abstract: The present invention belongs to the field of immunology and molecular biology, which relates to an anti-PCSK9 antibody, the pharmaceutical composition and method of use thereof. In particular, the present invention relates to the monoclonal antibody, which can bind PCSK9 specifically, block association of PCSK9 with LDLR, upregulate the amount of LDLR on cell surface, heighten the metabolism of LDL cholesterol and/or triglycerides, and prevent/treat cardiovascular diseases caused by hypercholesterolemia.
    Type: Grant
    Filed: April 22, 2020
    Date of Patent: August 2, 2022
    Assignee: AD Pharmaceutical Co., Inc.
    Inventors: Baiyong Li, Zhongmin Wang, Yu Xia, Peng Zhang, Wuxian Ren, Jinan Jiao, Yuanyuan Xu, Dongsheng Dai
  • Publication number: 20210201458
    Abstract: Provided are a face image processing method and apparatus, an image device, and a storage medium. The face image processing method includes: acquiring first-key-point information of a first face image; performing position transformation on the first-key-point information to obtain second-key-point information conforming to a second facial geometric attribute, the second facial geometric attribute being different from a first facial geometric attribute corresponding to the first-key-point information; and performing facial texture coding processing by utilizing a neural network and the second-key-point information to obtain a second face image.
    Type: Application
    Filed: March 16, 2021
    Publication date: July 1, 2021
    Inventors: Wenyan WU, Chen QIAN, Keqiang SUN, Qianyi WU, Yuanyuan XU
  • Publication number: 20210130817
    Abstract: The present invention relates to a CRISPR/Cas system comprising guide RNAs and a Cas protein, wherein the guide RNAs are composed of the following two parts: the guide RNAs are capable of respectively binding to two sequences of target sequences having SEQ ID NO: 2, SEQ NO: 3 and SEQ ID NO: 4 in eukaryotic B2M genes. The system exhibits a relatively high single-gene knockout rate for B2M. The present invention further relates to a gene editing method for T cells using the system, which method provides an efficient, safe and simple process for producing universal T cells.
    Type: Application
    Filed: June 25, 2018
    Publication date: May 6, 2021
    Inventors: Yanni Lin, Yuanyuan Xu, Jun Li
  • Patent number: 10918645
    Abstract: Provided are a substituted tricyclic heterocyclic compound of formula I or a stereoisomer, a tautomer, an N-oxide, a hydrate, a solvate, a metabolite, a pharmaceutically acceptable salt, ester or a prodrug thereof, a pharmaceutical composition including the same and uses thereof. The substituted tricyclic heterocyclic compounds and the pharmaceutical compositions comprising the compounds disclosed herein can be used for treating a disorder caused by at least one of cancer and neurodegenerative diseases. Further the compounds and the pharmaceutical compositions comprising the compounds disclosed herein can be also used for preventing or treating a disorder caused by, associated with or accompanied by any abnormal kinase activity.
    Type: Grant
    Filed: June 13, 2017
    Date of Patent: February 16, 2021
    Assignees: LIFEARC, SUZHOU YABAO PHARMACEUTICAL R&D CO., LTD.
    Inventors: Yan Xia, Edward Giles McIver, Yang Song, Yuanyuan Xu, Lin Zhu, Chunjun Chu, Ling Wu, Miao Liu, Justin Stephen Bryans
  • Publication number: 20200319185
    Abstract: The present invention belongs to the field of immunology and molecular biology, which relates to an anti-PCSK9 antibody, the pharmaceutical composition and method of use thereof. In particular, the present invention relates to the monoclonal antibody, which can bind PCSK9 specifically, block association of PCSK9 with LDLR, upregulate the amount of LDLR on cell surface, heighten the metabolism of LDL cholesterol and/or triglycerides, and prevent/treat cardiovascular diseases caused by hypercholesterolemia.
    Type: Application
    Filed: April 22, 2020
    Publication date: October 8, 2020
    Inventors: Baiyong LI, Zhongmin Wang, Yu Xia, Peng Zhang, Wuxian Ren, Jinan Jiao, Yuanyuan Xu, Dongsheng Dai
  • Patent number: 10670604
    Abstract: The present invention belongs to the field of immunology and molecular biology, which relates to an anti-PCSK9 antibody, the pharmaceutical composition and method of use thereof. In particular, the present invention relates to the monoclonal antibody, which can bind PCSK9 specifically, block association of PCSK9 with LDLR, upregulate the amount of LDLR on cell surface, heighten the metabolism of LDL cholesterol and/or triglycerides, and prevent/treat cardiovascular diseases caused by hypercholesterolemia.
    Type: Grant
    Filed: February 4, 2016
    Date of Patent: June 2, 2020
    Assignee: AD Pharmaceutical Co., Inc.
    Inventors: Baiyong Li, Zhongmin Wang, Yu Xia, Peng Zhang, Wuxian Ren, Jinan Jiao, Yuanyuan Xu, Dongsheng Dai
  • Publication number: 20190307763
    Abstract: Provided are a substituted tricyclic herteocyclic compound of formula I or a stereoisomer, a tautomer, an N-oxide, a hydrate, a solvate, a metabolite, a pharmaceutically acceptable salt, ester or a prodrug thereof, a pharmaceutical composition including the same and uses thereof. The substituted tricyclic herteocyclic compounds and the pharmaceutical compositions comprising the compounds disclosed herein can be used for treating a disorder caused by at least one of cancer and neurodegenerative diseases. Further the compounds and the pharmaceutical compositions comprising the compounds disclosed herein can be also used for preventing or treating a disorder caused by, associated with or accompanied by any abnormal kinase activity.
    Type: Application
    Filed: June 13, 2017
    Publication date: October 10, 2019
    Applicants: LifeArc, Suzhou Yabao Pharmaceutical R&D Co., Ltd.
    Inventors: Yan XIA, Edward Giles MCIVER, Yang SONG, Yuanyuan XU, Lin ZHU, Chunjun CHU, Ling WU, Miao LIU, Justin Stephen BRYANS
  • Patent number: 10356560
    Abstract: Disclosed are an indication direction-based instruction transmission method and apparatus, a smart device and a storage medium. According to the method, after a first smart device receives a first instruction, a current orientation of a set orientation on the first smart device is determined. It is detected whether there is at least one second smart device in the current orientation or not, and a first detection result is generated. When the first detection result represents that there is at least one second smart device in the current orientation, the first instruction is sent to at least one second smart device in the detected at least one second smart device to enable the at least one second smart device receiving the first instruction to execute the first instruction.
    Type: Grant
    Filed: August 31, 2015
    Date of Patent: July 16, 2019
    Assignee: ZTE Corporation
    Inventors: Baisheng Zhang, Yuanyuan Xu, Min Fu, Jiangchao Qian
  • Patent number: 10289914
    Abstract: A method, system, and device for processing video shooting are described. The method includes: shooting a subject in a background sample, the background sample, and a target background respectively, to generate a first video recording the subject and the background sample, a second video recording the background sample, and a third video recording the target background respectively, the shooting time lengths of the first video and the second video being smaller than the shooting time length of the third video; and comparing the first video and the second video, extracting images of the subject from the first video, generating a subject image frame sequence with a transparent background, sequentially superimposing each subject image frame in the subject image frame sequence to the third video, and generating a video file recording the subject and the target background.
    Type: Grant
    Filed: March 2, 2015
    Date of Patent: May 14, 2019
    Assignee: ZTE Corporation
    Inventors: Jianjiang Chen, Yuanyuan Xu
  • Publication number: 20180270617
    Abstract: Disclosed are an indication direction-based instruction transmission method and apparatus, a smart device and a storage medium. According to the method, after a first smart device receives a first instruction, a current orientation of a set orientation on the first smart device is determined. It is detected whether there is at least one second smart device in the current orientation or not, and a first detection result is generated. When the first detection result represents that there is at least one second smart device in the current orientation, the first instruction is sent to at least one second smart device in the detected at least one second smart device to enable the at least one second smart device receiving the first instruction to execute the first instruction.
    Type: Application
    Filed: August 31, 2015
    Publication date: September 20, 2018
    Inventors: Baisheng Zhang, Yuanyuan Xu, Min Fu, Jiangchao Qian
  • Publication number: 20180159975
    Abstract: A method and device for reminding contact modes are disclosed. In some embodiments, the method includes: a calling end initiates a call and detects a call state of a call; and interaction information used for inquiring whether to send a short message to a current call number is displayed if a detected call state shows that a called end is busy.
    Type: Application
    Filed: August 10, 2015
    Publication date: June 7, 2018
    Inventors: Haiqi ZHAO, Yuanyuan XU